anonymous
Guest
anonymous
Guest
What's in the pipeline for the OBU?
Crickets.
No R&D, Vickers bailed, and what about the unique conjunctivitis drug? I'm sure that will be a "game changer" for the OBU, not.
Buyers remorse has to be rampant in the OBU. Most left good, if not perfect, companies to come over and for what?
One drug in the bag, shitty reputation among ECP's, and leadership that can't even communicate a plan. Pathetic.
Crickets.
No R&D, Vickers bailed, and what about the unique conjunctivitis drug? I'm sure that will be a "game changer" for the OBU, not.
Buyers remorse has to be rampant in the OBU. Most left good, if not perfect, companies to come over and for what?
One drug in the bag, shitty reputation among ECP's, and leadership that can't even communicate a plan. Pathetic.